Industry

AI-generated text

OpenEvidence CEO urges medical students to learn without relying on AI

OpenEvidence CEO Daniel Nadler says medical students should master their subject through traditional study and paper exams, even if they also use AI.

OpenEvidence CEO urges medical students to learn without relying on AI

Medical students should master their subjects through traditional methods and demonstrate their knowledge in paper exams, even if they also use artificial intelligence, Daniel Nadler, CEO of medical AI company OpenEvidence, said on Monday.

Speaking to Mohammed Sergie at Semafor’s Silicon Valley & The World event, Nadler warned that the risk of handing cognitive tasks over to AI is particularly acute. Students, he argued, should also follow the harder, traditional path of learning so they can be sure they actually know the material.

OpenEvidence synthesizes complex medical information using AI trained on millions of medical papers. The company is built on the premise that the technology can make the field’s complicated knowledge easier for physicians to digest; the startup has reached a valuation of $15 billion.

Offloading cognitive tasks can lead to a loss of skills. Early research has found that delegating work to AI can weaken neural networks and reduce cognitive performance. Nadler said the concern is especially pressing for younger generations who grew up with access to AI in academic settings. At the same time, he noted that all of his company’s engineers use numerous AI assistants.

AI in drug development

Also speaking at Monday’s event, Benjamine Liu, CEO of Formation Bio, which uses AI to accelerate drug development, said AI systems in the pharmaceutical industry can now begin to perform the work of entire teams.

Liu told Sergie that some people underestimate the size of the pharmaceutical industry: makers of GLP-1 drugs generated more revenue last year than OpenAI and Anthropic combined. He said developments that could help people live longer, healthier lives are still at an early stage, even though the technology industry sometimes overlooks the area.